You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SSRIs

Showing 1 - 25 of 450
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Depression Trial in Shanghai (Mianserin, Lorazepam)

Not yet recruiting
  • Depression
  • Shanghai, China
    Shanghai Mental Health Center
Oct 26, 2022

MDD Trial in Manchester, Liverpool (SPL026)

Recruiting
  • Major Depressive Disorder
  • Manchester, Greater Manchester, United Kingdom
  • +1 more
Jan 18, 2023

Depression, MDD, Mild Depression Trial in Abbotsford (Psilocybin)

Not yet recruiting
  • Depression
  • +4 more
  • Abbotsford, British Columbia, Canada
    Centre for Neurology Studies x Upstream
Oct 25, 2022

MDD Trial (Vortioxetine, Sertraline, citalopram)

Active, not recruiting
  • Major Depressive Disorder
  • Catanzaro, Italy
  • +2 more
Oct 7, 2022

MDD Trial in Hangzhou (SSRIs, acupuncture, sham acupuncture)

Not yet recruiting
  • Major Depressive Disorder
  • SSRIs
  • +3 more
  • Hangzhou, Zhejiang, China
    Xiaomei Medical Shao
Apr 27, 2022

Hypercapnia, Ventilatory Depression Trial in West Bend (Placebo and Oxycodone, Paroxetine and Oxycodone, Escitalopram and

Not yet recruiting
  • Hypercapnia
  • Ventilatory Depression
  • Placebo and Oxycodone
  • +2 more
  • West Bend, Wisconsin
    Spaulding Clinical Research
Jul 20, 2022

Social Anxiety Disorder Trial in Tel Aviv (Gaze Contingent Music Reward Therapy, Escitalopram, Waitlist)

Completed
  • Social Anxiety Disorder
  • Gaze Contingent Music Reward Therapy
  • +2 more
  • Tel Aviv, Israel
    Tel Aviv University
Jan 31, 2022

Do Serotonin Reuptake Inhibitors Affect Bone Mass in Adolescents

Completed
Has Results
  • The Skeletal Effects of SSRIs
    • Iowa City, Iowa
      University of Iowa Hospitals and Clinics
    Dec 27, 2021

    Haemorrhage Between Vortioxetine Tablet Treatment and Selective

    Not yet recruiting
    • Major Depressive Disorder
    • Vortioxetine Tablet
    • SSRI
    • (no location specified)
    Jun 28, 2023

    MDD Trial in Shanghai (SSRIs, SSRI plus Sulforaphane)

    Recruiting
    • Major Depressive Disorder
    • SSRIs
    • SSRI plus Sulforaphane
    • Shanghai, China
      Shanghai Mental Health Center
    Dec 6, 2021

    Depression Trial in Xi'an (Transcranial magnetic stimulation)

    Recruiting
    • Depression
    • Transcranial magnetic stimulation
    • Xi'an, Shannxi, China
      XijingH
    Dec 26, 2022

    MDD Trial in Hangzhou (SSRIs, acupuncture (strong reaction acupoints), acupuncture (weak reaction acupoints))

    Not yet recruiting
    • Major Depressive Disorder
    • SSRIs
    • +3 more
    • Hangzhou, Zhejiang, China
      the Third affiliated hospital of Zhejiang Chinese Medical univer
    Apr 28, 2022

    Stroke, Motor Trial (device, drug, behavioral)

    Not yet recruiting
    • Stroke
    • Motor
    • tDCS
    • +2 more
    • (no location specified)
    Sep 10, 2021

    Geriatric Depression, Cognitive Impairment Trial in Beijing (Selective Serotonin Reuptake Inhibitor(SSRIs,Fluoxetine,

    Recruiting
    • Geriatric Depression
    • Cognitive Impairment
    • Selective Serotonin Reuptake Inhibitor（SSRIs，Fluoxetine, paroxetine, fluvoxamine, sertraline, citalopram, escitalopram）
    • Beijing, China
      Beijing Anding Hospital Affiliated to Capital Medical University
    Oct 18, 2022

    MDD Trial in Hangzhou (SSRIs, SIA, AIA)

    Recruiting
    • Major Depressive Disorder
    • SSRIs
    • +2 more
    • Hangzhou, Zhejiang, China
      the Third affiliated hospital of Zhejiang Chinese Medical univer
    Nov 2, 2022

    Epilepsy Trial in Shanghai (psychology therapy)

    Active, not recruiting
    • Epilepsy
    • psychology therapy
    • Shanghai, Shanghai, China
      Department of Neurology, Zhongshan Hospital, Fudan University, S
    Dec 19, 2021

    Generalized Anxiety Disorder Trial in Kingston (SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and

    Completed
    • Generalized Anxiety Disorder
    • SSRIs/SNRIs (Selective Serotonin Reuptake Inhibitors/ Serotonin and Norepinephrine Reuptake Inhibitors)
    • Electronic Cognitive Behavioural Therapy
    • Kingston, Ontario, Canada
      Hotel Dieu Hospital
    Sep 7, 2021

    SSRI's and the Rate of Progression From MCI to Dementia

    Recruiting
    • Mild Cognitive Impairment
    • +2 more
    • Columbus, Ohio
      The Ohio State University
    Sep 8, 2021

    Depression, MDD, Dysthymic Disorder Trial in Indianapolis (behavioral, drug, other)

    Recruiting
    • Depression
    • +6 more
    • Good Days Ahead (GDA)
    • +3 more
    • Indianapolis, Indiana
      IUPUI Department of Psychology
    Jan 18, 2022

    Antidepressants in Advance of Investigational Trials, Relapse

    Recruiting
    • Major Depressive Disorder
    • FDA-approved selective-serotonin reuptake inhibitors (SSRIs) and selective-norepinephrine reuptake inhibitors (SNRIs)
    • Watertown, Massachusetts
      Adams Clinical
    Jun 14, 2021

    Antidepressants in Advance of Investigational Trials

    Recruiting
    • Major Depressive Disorder
    • FDA-approved selective-serotonin reuptake inhibitors (SSRIs) and selective-norepinephrine reuptake inhibitors (SNRIs)
    • Watertown, Massachusetts
      Adams Clinical
    Mar 9, 2021

    MDD Trial in Changsha (Agomelatine, Placebos)

    Unknown status
    • MDD
    • Changsha, Hunan, China
      Mental Health Institute & Faculty of Psychiatry of The Second Xi
    Oct 9, 2020

    Depression, MDD, Dysthymic Disorder Trial in Indianapolis (behavioral, drug, other)

    Completed
    Has Results
    • Depression
    • +7 more
    • Beating the Blues (BtB)
    • +3 more
    • Indianapolis, Indiana
      IUPUI Department of Psychology
    Aug 30, 2021

    OCD, Anxiety Disorders, Mental Disorders Trial in Shanghai (Fluoxetine, Sertraline, Paroxetine)

    Completed
    • Obsessive-Compulsive Disorder
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Mental Health Center
    Aug 12, 2020

    Depressive Disorder, Major Trial in Be'er Ya'aqov, Zürich (Opti-Me)

    Unknown status
    • Depressive Disorder, Major
    • Opti-Me
    • Be'er Ya'aqov, Israel
    • +1 more
    Feb 15, 2021